🇺🇸 Bimatoprost Ophthalmic Solution 0.01% in United States

Bimatoprost Ophthalmic Solution 0.01% (Bimatoprost Ophthalmic Solution 0.01%) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Bimatoprost Ophthalmic Solution 0.01% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bimatoprost Ophthalmic Solution 0.01% approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bimatoprost Ophthalmic Solution 0.01% in United States?

Allergan is the originator. The local marketing authorisation holder may differ — check the official source linked above.